Vanta closes second tranche of private placement financing
The company also pointed to the launch of what it calls the first U.S.-listed peptide ETF as a sign of investor attention to the sector.
The wire
- 01Vanta announced the closing of a second tranche of its private placement financing, according to the company's release.
- 02Peptide-focused financings and a dedicated U.S.-listed ETF indicate capital is organizing around the sector that supplies and develops these drugs.
- 03The announcement is company-issued and does not detail proceeds, use of funds or clinical milestones.
From the source
Read at lelezard.comVanta Closes Second Tranche of Private Placement Financing and Welcomes Launch of First U.S.-Listed Peptide ETF, Highlighting Growing Recognition of Peptide Industry
